U.S. markets closed
  • S&P 500

    3,841.47
    -11.60 (-0.30%)
     
  • Dow 30

    30,996.98
    -179.03 (-0.57%)
     
  • Nasdaq

    13,543.06
    +12.15 (+0.09%)
     
  • Russell 2000

    2,168.76
    +27.34 (+1.28%)
     
  • Crude Oil

    51.98
    -1.15 (-2.16%)
     
  • Gold

    1,855.50
    -10.40 (-0.56%)
     
  • Silver

    25.57
    -0.29 (-1.12%)
     
  • EUR/USD

    1.2174
    +0.0001 (+0.01%)
     
  • 10-Yr Bond

    1.0910
    -0.0180 (-1.62%)
     
  • GBP/USD

    1.3685
    -0.0046 (-0.33%)
     
  • USD/JPY

    103.7500
    +0.2450 (+0.24%)
     
  • BTC-USD

    32,430.43
    +636.10 (+2.00%)
     
  • CMC Crypto 200

    651.44
    +41.45 (+6.79%)
     
  • FTSE 100

    6,695.07
    -20.35 (-0.30%)
     
  • Nikkei 225

    28,631.45
    -125.41 (-0.44%)
     

Regenxbio Inc (RGNX) CFO Vittal Vasista Sold $796,685 of Shares

GuruFocus.com
·2 min read

- By insider

CFO of Regenxbio Inc (30-Year Financial, Insider Trades) Vittal Vasista (insider trades) sold 16,239 shares of RGNX on 01/08/2021 at an average price of $49.06 a share. The total sale was $796,685.


Regenxbio Inc is a biotechnology company. It is engaged in the development, commercialization and licensing of recombinant adeno-associated virus gene therapy. Regenxbio Inc has a market cap of $1.8 billion; its shares were traded at around $48.130000 with and P/S ratio of 12.72. GuruFocus has detected 2 severe warning signs with Regenxbio Inc. .

CEO Recent Trades:

  • President and CEO Kenneth T. Mills sold 1,500 shares of RGNX stock on 01/07/2021 at the average price of $50.01. The price of the stock has decreased by 3.76% since.

  • President and CEO Kenneth T. Mills sold 6,500 shares of RGNX stock on 12/28/2020 at the average price of $48.67. The price of the stock has decreased by 1.11% since.

  • President and CEO Kenneth T. Mills sold 4,500 shares of RGNX stock on 12/23/2020 at the average price of $50. The price of the stock has decreased by 3.74% since.

  • President and CEO Kenneth T. Mills sold 15,000 shares of RGNX stock on 12/16/2020 at the average price of $45. The price of the stock has increased by 6.96% since.

CFO Recent Trades:

  • CFO Vittal Vasista sold 16,239 shares of RGNX stock on 01/08/2021 at the average price of $49.06. The price of the stock has decreased by 1.9% since.

  • CFO Vittal Vasista sold 24,500 shares of RGNX stock on 12/24/2020 at the average price of $50.01. The price of the stock has decreased by 3.76% since.

Directors and Officers Recent Trades:

  • Chief Oper. & Tech. Officer Curran Simpson sold 5,185 shares of RGNX stock on 01/07/2021 at the average price of $50.01. The price of the stock has decreased by 3.76% since.

For the complete insider trading history of RGNX, click here

.This article first appeared on GuruFocus.